Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "pulmonary-fibrosis"

NewsRSSApr 29

Test Your Knowledge About Nintedanib for the Treatment of PPF

This article is a quiz that tests what you know about nintedanib, a medication used to treat progressive pulmonary fibrosis (PPF). Progressive pulmonary fibrosis is a lung disease where lung tissue becomes scarred and stiff over time, making it harder to breathe. The quiz helps patients and caregivers learn more about how this drug works and its role in treatment.

WHY IT MATTERSUnderstanding how nintedanib works can help patients with PPF make informed decisions about their treatment options and have more meaningful conversations with their doctors about managing their condition.
Good to knowprogressive pulmonary fibrosis

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases